135 related articles for article (PubMed ID: 30652589)
1. Quality of Clinician-Reported Cancer History When Ordering Genetic Testing.
LaDuca H; McFarland R; Gutierrez S; Yussuf A; Ho N; Pepper J; Reineke P; Cain T; Blanco K; Horton C; Dolinsky JS
JCO Clin Cancer Inform; 2018 Dec; 2():1-11. PubMed ID: 30652589
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
3. Should all patients undergoing genetic testing for hereditary breast cancer syndromes be offered a multigene panel?
Silver EL; Niell-Swiller M
Curr Opin Obstet Gynecol; 2022 Feb; 34(1):36-40. PubMed ID: 34967813
[TBL] [Abstract][Full Text] [Related]
4. Hereditary susceptibility to breast cancer: significance of age of onset in family history and contribution of BRCA1 and BRCA2.
Frank TS; Deffenbaugh AM; Hulick M; Gumpper K
Dis Markers; 1999 Oct; 15(1-3):89-92. PubMed ID: 10595259
[TBL] [Abstract][Full Text] [Related]
5. Hereditary cancer-associated mutations in women diagnosed with two primary cancers: an opportunity to identify hereditary cancer syndromes after the first cancer diagnosis.
Saam J; Moyes K; Landon M; Williams K; Kaldate RR; Arnell C; Wenstrup R
Oncology; 2015; 88(4):226-33. PubMed ID: 25503195
[TBL] [Abstract][Full Text] [Related]
6. Lack of referral for genetic counseling and testing in BRCA1/2 and Lynch syndromes: a nationwide study based on 240,134 consultations and 134,652 genetic tests.
Pujol P; Lyonnet DS; Frebourg T; Blin J; Picot MC; Lasset C; Dugast C; Berthet P; de Paillerets BB; Sobol H; Grandjouan S; Soubrier F; Buecher B; Guimbaud R; Lidereau R; Jonveaux P; Houdayer C; Giraud S; Olschwang S; Nogue E; Galibert V; Bara C; Nowak F; Khayat D; Nogues C
Breast Cancer Res Treat; 2013 Aug; 141(1):135-44. PubMed ID: 23974829
[TBL] [Abstract][Full Text] [Related]
7. Significance of the Multi-gene Panel myRisk in Japan.
Hayashi S; Kubo M; Matsuzaki S; Kai M; Morisaki T; Yamada M; Kaneshiro K; Takao Y; Shimazaki A; Nagayoshi K; Mizuuchi Y; Nakamura M
Anticancer Res; 2022 Aug; 42(8):4097-4102. PubMed ID: 35896222
[TBL] [Abstract][Full Text] [Related]
8. Mutation prevalence tables for hereditary cancer derived from multigene panel testing.
Hart SN; Polley EC; Yussuf A; Yadav S; Goldgar DE; Hu C; LaDuca H; Smith LP; Fujimoto J; Li S; Couch FJ; Dolinsky JS
Hum Mutat; 2020 Aug; 41(8):e1-e6. PubMed ID: 32442341
[TBL] [Abstract][Full Text] [Related]
9. Accuracy of cancer family histories: comparison of two breast cancer syndromes.
Schneider KA; DiGianni LM; Patenaude AF; Klar N; Stopfer JE; Calzone KA; Li FP; Weber BL; Garber JE
Genet Test; 2004; 8(3):222-8. PubMed ID: 15727243
[TBL] [Abstract][Full Text] [Related]
10. Risk of cancer in relatives of prostate cancer probands.
Isaacs SD; Kiemeney LA; Baffoe-Bonnie A; Beaty TH; Walsh PC
J Natl Cancer Inst; 1995 Jul; 87(13):991-6. PubMed ID: 7629886
[TBL] [Abstract][Full Text] [Related]
11. Genetic testing and prevention of hereditary cancer at the MMCI--over 10 years of experience.
Foretova L; Petrakova K; Palacova M; Kalabova R; Svoboda M; Navratilova M; Schneiderova M; Bolcak K; Krejci E; Drazan L; Mikova M; Hazova J; Vasickova P; Machackova E
Klin Onkol; 2010; 23(6):388-400. PubMed ID: 21348412
[TBL] [Abstract][Full Text] [Related]
12. Hereditary nonpolyposis colorectal cancer: diagnostic strategies and their implications.
Bonis PA; Trikalinos TA; Chung M; Chew P; Ip S; DeVine DA; Lau J
Evid Rep Technol Assess (Full Rep); 2007 May; (150):1-180. PubMed ID: 17764220
[TBL] [Abstract][Full Text] [Related]
13. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
14. Hereditary cancer syndromes, their testing and prevention.
Foretová L
Cas Lek Cesk; 2019; 158(1):15-21. PubMed ID: 31046387
[TBL] [Abstract][Full Text] [Related]
15. Hereditary breast-ovarian cancer: clinical findings and medical management.
Marshall M; Solomon S
Plast Surg Nurs; 2007; 27(3):124-7. PubMed ID: 17901820
[TBL] [Abstract][Full Text] [Related]
16. Multigene Testing for Hereditary Cancer: When, Why, and How.
Offit K
J Natl Compr Canc Netw; 2017 May; 15(5S):741-743. PubMed ID: 28515260
[TBL] [Abstract][Full Text] [Related]
17. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
[TBL] [Abstract][Full Text] [Related]
18. Advances in the diagnosis of hereditary kidney cancer: Initial results of a multigene panel test.
Nguyen KA; Syed JS; Espenschied CR; LaDuca H; Bhagat AM; Suarez-Sarmiento A; O'Rourke TK; Brierley KL; Hofstatter EW; Shuch B
Cancer; 2017 Nov; 123(22):4363-4371. PubMed ID: 28787086
[TBL] [Abstract][Full Text] [Related]
19. Patients Tested at a Laboratory for Hereditary Cancer Syndromes Show an Overlap for Multiple Syndromes in Their Personal and Familial Cancer Histories.
Saam J; Arnell C; Theisen A; Moyes K; Marino I; Roundy KM; Wenstrup RJ
Oncology; 2015; 89(5):288-93. PubMed ID: 26315041
[TBL] [Abstract][Full Text] [Related]
20. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]